Back to Search Start Over

Research Needs to Improve Hypertension Treatment and Control in African Americans

Authors :
Paul L. Kimmel
Paul Muntner
George Thomas
Keith C. Ferdinand
Paula T. Einhorn
Gbenga Ogedegbe
Barry L. Carter
William C. Cushman
Sung Sug Sarah Yoon
Paul K. Whelton
Michael Rakotz
Lisa A. Cooper
Richard S. Cooper
Barry I. Freedman
Katherine T. Mills
Lawrence J. Appel
Barry R. Davis
Jackson T. Wright
Mahboob Rahman
Jamy D. Ard
Jonathan N. Tobin
Jeffrey A. Cutler
Donna K. Arnett
Karen L. Margolis
Nara Gavini
George A. Mensah
Edgar R. Miller
Alan S. Go
David J. Hyman
Herman A. Taylor
Patrice Desvigne-Nickens
Ana V. Diez Roux
Ann Marie Navar
Source :
Scopus-Elsevier
Publication Year :
2016
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2016.

Abstract

This report presents findings of an ad hoc working group assembled by the National Heart, Lung, and Blood Institute (NHLBI) to assess research needs to improve prevention, treatment, and control of hypertension among African Americans. Non-Hispanic Blacks (African American and Black will be used for US and international studies, respectively) tend to have an earlier onset, higher prevalence, and disproportionately high risk of complications for hypertension compared with non-Hispanic Whites and Mexican Americans.1 Surveys identify substantial variation in mean blood pressure (BP) among populations of African origin.2 In high-income countries, including the United States, mean BP and prevalence of hypertension are higher in adults self-described,3–6 observer reported,7,8 or otherwise identified9,10 as being black or having darker skin color.11 However, the relationship between African origin and BP is absent or only minimally apparent in reports from middle-income countries.12–14 Research to clarify reasons for this variability may contribute to understanding of hypertension-related racial disparities in the United States. In US National Health and Nutrition Examination Survey (NHANES) reports, crude and age-adjusted prevalence of hypertension (systolic BP [SBP] ≥140 mm Hg, diastolic BP ≥90 mm Hg, or taking antihypertensive medication) in adults has remained fairly constant at ≈30% since 1999 to 2000.3,4 The corresponding prevalence estimate for African Americans is ≈40% and has also remained reasonably stable. In African Americans, hypertension awareness and treatment rates are higher but control rates lower compared with non-Hispanic Whites (85.7% versus 82.7% for awareness, 77.4% versus 76.7% for treatment, and 49.5% versus 53.9% for control in NHANES 2011–2012).4 The lower prevalence of BP control is present despite use of more BP-lowering medications, including thiazide diuretics.15 This contrasts with clinical trial experience, where differences in BP control rates by race/ethnicity …

Details

ISSN :
15244563 and 0194911X
Volume :
68
Database :
OpenAIRE
Journal :
Hypertension
Accession number :
edsair.doi.dedup.....fe81c88d01a5084359e377adfc00010b